Wael Richeh1, Tyler Arnwine 2
1Neurology, Shannon Clinic, 2Neurology, Shannon clinic
Objective:
The primary objective of this study was to evaluate the efficacy of the new Fibrolux laser therapy in Fibromyalgia patients.
Background:
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness. Fibrolux is a newly FDA cleared laser therapy , specifically used for the treatment of fibromyalgia. This study evaluated the effectiveness of Fibrolux laser therapy in reducing pain in fibromyalgia patients.
Design/Methods:
This study is a retrospective, single-arm, pre-post intervention study.
The study was conducted over a period of 12 weeks.
At Sahnnon clinic, Brain and Spine Institute. in San Angelo, Texas.
50 fibromyalgia patients were recruited for this study.
All Participants underwent a comprehensive baseline assessment, including demographic data, medical history, fibromyalgia symptom severity, and pain scores.
All Participants received Fibrolux laser therapy sessions as per the manufacturer's recommended protocol.
Pain scores and fibromyalgia symptom severity was reassessed at 4, 8, and 12 weeks after the initiation of Fibrolux therapy.
Results:
The abstract presents a statistical analysis using a T-test to compare the average values of the widespread pain index (WPI) and pain intensity in fibromyalgia patients before and after treatment. The study focuses on the effects of Fibrolux laser therapy on these variables.
The average WPI value before treatment was 15, which significantly decreased to 5 after treatment (p < 0.05). This indicates a substantial reduction in the extent of widespread pain experienced by the patients.
Furthermore, the average pain intensity before treatment was reported as 7/10, which significantly decreased to 3/10 after treatment (p < 0.05). This demonstrates a significant improvement in pain intensity following Fibrolux laser therapy.
Conclusions:
The findings suggest that Fibrolux laser therapy has a positive impact on both the widespread pain index and pain intensity in fibromyalgia patients. Further research is warranted to explore the long-term effects and mechanisms underlying the observed improvements.